Format

Send to

Choose Destination
Chest. 2007 Mar;131(3):664-671. doi: 10.1378/chest.06-1885.

Respiratory bronchiolitis-interstitial lung disease: long-term outcome.

Author information

1
National Jewish Medical and Research Center, Denver, CO.
2
University of Colorado Health Sciences Center, Denver, CO.
3
University of California at San Francisco, San Francisco, CA.
4
National Jewish Medical and Research Center, Denver, CO. Electronic address: brownk@njc.org.

Abstract

BACKGROUND:

The clinical and physiologic features of respiratory bronchiolitis (RB)-interstitial lung disease (ILD) have been previously described; however, the natural history and outcome have not been systematically evaluated. The majority of published reports consider RB-ILD to be a nonprogressive ILD that clinically improves with smoking cessation and antiinflammatory treatment. In this study, we sought to determine the outcome of RB-ILD patients with and without smoking cessation and with and without corticosteroid therapy.

METHODS:

Thirty-two RB-ILD cases confirmed by surgical lung biopsy were identified from a prospectively enrolled cohort of subjects with ILD. Initial and follow-up data on symptoms, physiology, treatment, and outcome were collected and analyzed.

RESULTS:

Kaplan-Meier analysis revealed that at least 75% of RB-ILD patients survived > 7 years after diagnosis. Clinical improvement occurred in only 28% of cases, and physiologic improvement occurred in 10.5% of cases. One patient died of progressive ILD, and two patients died of non-small cell lung cancer. While physiologic improvement was limited to those who had ceased smoking, corticosteroids and/or other immunosuppressive therapy had little effect on symptoms or physiology.

CONCLUSIONS:

This study shows that prolonged survival is common in RB-ILD. However, symptomatic and physiologic improvement occurs in only a minority of patients, and neither smoking cessation nor immunosuppressive therapy is regularly associated with clinically significant benefit.

PMID:
17356078
DOI:
10.1378/chest.06-1885
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center